Yale’s Dr. Risch on Early Treatment of COVID-19

When Harvey Risch, M.D., Ph.D., published an article in the American Journal of Epidemiology in May 2020 about the safe and effective use of hydroxychloroquine (HCQ) as an early treatment in COVID-19 patients, he was criticized and attacked by some in the medical industry, including some of his own colleagues.